Ask about this productRelated genes to: Reck antibody
- Gene:
- RECK NIH gene
- Name:
- reversion inducing cysteine rich protein with kazal motifs
- Previous symbol:
- ST15
- Synonyms:
- hRECK
- Chromosome:
- 9p13.3
- Locus Type:
- gene with protein product
- Date approved:
- 1998-10-30
- Date modifiied:
- 2016-01-28
Related products to: Reck antibody
Related articles to: Reck antibody
- Modern patient-centered rehabilitation for critically ill patients focuses on physical, cognitive, psychological, and social recovery to reduce long-term impairments after critical illness. Core strategies include the ABCDEF (A2F) bundle/ICU Liberation, humanization programs, and symptom management. Based on the capabilities of individual patients, frequent assessments in these dimensions are performed to develop person-centered goals and interventions. Early mobilization, cognitive stimulation, delirium prevention and nonpharmacological management, empathic communication, ICU diaries, and family involvement should begin within 24 to 72 hours after ICU admission. The dosage and delivery of these interventions should be adapted to the capabilities and needs of individual patients. - Source: PubMed
Publication date: 2026/03/11
Nydahl PeterEggmann SabrinaEwens BevJones ChristinaKarnatovskaia Lioudmila VNeedham Dale M - The control of the cattle tick, Rhipicephalus (Boophilus) microplus, is an ongoing challenge for cattle producers in tropical and sub-tropical regions around the world. It is a robust parasite that transmits potentially fatal pathogens and can cause substantial damage to cattle in its own right. With a high fecundity and a life cycle with an off-host, free-living phase that can extend to around one year, R. microplus has a demonstrated capacity to both, evade treatment with acaricides and to acquire resistance to acaricides. The aim of this article is to design current best practice recommendations for control of R. microplus for Latin American environments, based on empirical and theoretical studies available in the literature, and on the field experiences of the authors. To help control program designers ensure that all critical factors are considered, a five-pointed approach to control is recommended: 1) Treat with the right product; 2) Treat using the right dose; 3) Treat the right animals; 4) Treat at the right time; 5) Use non-acaricidal methods. Consideration of each of these points should enable control of ticks consistent with three pillars of sustainable parasite control: 1) ensuring environmental and human safety; 2) enhancing the production of high-quality, high welfare animal products; and 3) preserving the financial viability of cattle farms. - Source: PubMed
Publication date: 2026/05/05
Sabatini G ABorges F ACosta-Junior L MCuore UCutolo AFiel C AJonsson N NLopes W D ZLópez-Osorio SMartins J RMolento MMonteiro C M OMorel NNava SParodi PPulido MReck JRodrigues D SRodriguez-Vivas R I - To compare the safety of conventional physiotherapy alone versus its combination with cycloergometry by analysing session interruptions and physiological tolerance in critically ill patients. Secondarily, efficacy was assessed through strength and functional related outcomes. - Source: PubMed
Publication date: 2026/04/30
Rialp GemmaGil IsabelRomero MariaMorey CatalinaSarubbo FiorellaForteza Catalina - Amphotericin B (AmB) remains the gold standard for treating invasive fungal infections, yet its clinical utility is frequently constrained by systemic nephrotoxicity. Localized administration routes have emerged as a sophisticated strategy to optimize the drug's therapeutic index, achieving high concentrations at the infection site while minimizing systemic exposure. This review presents the state of the art of non-intravenous (non-IV) AmB administration routes, synthesizing available evidence regarding their application as adjuvant or salvage therapies. - Source: PubMed
Publication date: 2026/04/25
Cavassin Francelise BridiRodrigues Laura Fernandade Souza Camila Vitoria Rosade Souza Frassato Juliade Oliveira Brenda Camila ReckQueiroz-Telles FlavioMagri Marcello Mihailenko Chaves - Ticks are obligate blood-feeding ectoparasites of major veterinary and medical importance, and their control relies heavily on synthetic acaricides, a strategy increasingly compromised by resistance and environmental concerns. Entomopathogenic fungi (EPF) have gained significant prominence as biological alternatives for integrated tick management. This review synthesizes over two decades of advances in fungal-based tick control, including recent field trials, formulation technologies, and omics-driven mechanistic insights. Evidence shows that species within the genera Metarhizium and Beauveria exhibit consistent pathogenicity against several ixodid ticks, although efficacy varies with fungal isolate, propagule type, formulation, and environmental conditions. Advances in omics approaches have improved understanding of infection mechanisms and tick immune responses, while formulation and delivery innovations have enhanced fungal stability and field persistence. Field studies demonstrate variable but promising efficacy, particularly when EPF are applied within integrated control strategies. However, important challenges remain, including limited large-scale field validation and optimization of formulations. By integrating laboratory, field, and commercial evidence across production systems, this review identifies key technological bottlenecks and highlights future directions for climate-resilient and sustainable tick control. - Source: PubMed
Publication date: 2026/04/20
Golo Patrícia SilvaFiorotti JéssicaAngelo Isabele da CostaMarciano Allan FelipeCamargo Mariana GuedesMonteiro Caio Marcio de OliveiraPerinotto Wendell Marcelo de SouzaFernandes Éverton Kort KampReck JoséBittencourt Vânia Rita Elias Pinheiro